Reset all filters
01 1NOVARTIS
Reset all filters
01 1SOLUTION;INTRAVENOUS
Reset all filters
01 1RX
Reset all filters
01 1PLUVICTO
01 1Yes
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : Yes
TE Code :
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN
Novartis Pharmaceuticals Corporation
Dosage Form : SOLUTION; INTRAVENOUS
Proprietary Name : PLUVICTO
Dosage Strength : 27mCi/ML
Approval Date : 2022-03-23
Application Number : 215833
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
